Collection of Venous and Capillary Blood Samples Research, Optimization and Calibration of New Diagnostic Devices
When you are unwell, waiting for blood test results can take hours. This study aims to help improve a portable testing device called the cobas® lumira. This machine is designed to test blood right at a patient's bedside, giving healthcare staff fast and accurate results. To make sure the new device works safely and reliably, researchers across the UK are collecting blood samples from people with various health conditions. These include heart disease, diabetes, infections, kidney disease, liver conditions, blood clots, high cholesterol, and people taking blood-thinning medications like warfarin. If you take part, a healthcare worker will collect a routine blood sample from your arm, and possibly a tiny drop from a finger-prick. Your medical treatment will stay the same, but your sample will help improve diagnostic tools for future NHS patients.
At a glance
What is this study about?
When doctors need to make decisions about your care, they often rely on blood tests. In most hospitals and clinics, blood samples have to be sent away to a central laboratory. While laboratory testing is very accurate, transporting the samples and waiting for results can take hours or even days. Point-of-care testing devices aim to change this by allowing doctors and nurses to test blood right at your bedside and get results within minutes.
The EVOLVE study focuses on testing and fine-tuning a portable device called the cobas® lumira. To prove that this device works just as well as standard laboratory machines, scientists need to test real blood samples from people with different medical conditions. They are studying blood from people with heart problems, infections, kidney disease, diabetes, liver disorders, blood clots, and high cholesterol, as well as people on specific blood thinners.
By taking part, you provide blood samples that allow researchers to calibrate the testing strips and confirm their accuracy. The study will not change your personal care plan, but the information gathered could help hospitals, A&E departments, and GP surgeries make faster, life-saving decisions for patients in the future.
Key takeaways
- The study tests a new portable device designed to give rapid blood test results at the bedside.
- Participation involves giving a routine blood sample from your arm and possibly a finger-prick.
- Open to people with specific conditions, including diabetes, heart issues, kidney problems, and infections.
- It requires no extra hospital visits, overnight stays, or changes to your current medications.
- Your standard medical care will continue as normal throughout.
Who may be eligible?
You may be able to join this study if you are currently attending a participating UK hospital, ward, or clinic with specific health conditions. These include blood clots, infections, heart disease, kidney problems, liver conditions, high cholesterol, or diabetes. You may also qualify if you have been taking a blood-thinning medicine known as a vitamin K antagonist (such as warfarin) for at least four weeks.
Most participants must be aged 18 or older. However, young people aged 16 and over can take part if they are being tested for suspected pre-diabetes or have been diagnosed with type 1 or type 2 diabetes.
You cannot take part if you have already been enrolled in this study within the last 60 days. People in the blood-thinner group cannot join if they take newer types of blood thinners (such as apixaban or rivaroxaban), have a condition called antiphospholipid syndrome, or have recently taken part in an experimental medication trial.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older (or aged 16+ with diabetes or suspected pre-diabetes).
- I am currently receiving care at a participating UK hospital, clinic, or A&E department.
- I have one of the target conditions (such as heart disease, kidney issues, liver problems, diabetes, or an infection) or take warfarin.
- I have not taken part in the EVOLVE study in the past 60 days.
- I am willing to provide a blood sample for research.
What does participation involve?
Taking part is simple and usually takes place during your planned hospital or clinic visit. You will not need to make extra trips, take new medicines, or stay overnight. A healthcare professional will take a standard blood sample from a vein in your arm, and they might also collect a tiny drop of blood using a quick finger-prick. Your samples will be given a code so that your personal details remain private. There is no long-term follow-up, and your total involvement usually takes less than an hour on a single day.
Potential risks and benefits
Locations (1)
- Golden Jubilee National HospitalVerified postcodeGlasgow, United Kingdom· Recruiting
Common questions
Will taking part change my normal treatment?
No. The study only involves collecting blood samples. Your regular medical care, medicines, and treatment plan will carry on as normal.
How much blood will be taken?
Usually, only a standard blood sample from your arm and possibly a small drop from a finger-prick are needed.
Will I get my test results from the study machine?
No. The tests done on the new device are for research and calibration purposes only. Your doctors will continue to use standard laboratory tests to guide your care.
Is my personal information kept safe?
Yes. Your samples and data are pseudonymised, meaning your name and identifying details are replaced with a code before being analysed.
Can I leave the study if I change my mind?
Yes, you can withdraw at any time without giving a reason, and your medical care will not be affected.
How to find out more
Zoe Pounce, PhD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.